Work

A phase I-II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 on days 1 and 15 every 28 days in non-Hodgkin or Hodgkin lymphoma

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.8539

Authors: O. A. O’Connor, A. Goy, R. Orlowski, J. D. Hainsworth, J. P. Leonard, B. Afanasyev, D. Osmanov, M. Chen, A. Wolff

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W199354803

Cites:

Cited by: 7

Related to: 10